Gunderson Dettmer advises Natera, Inc. in Follow-on Public Offering

July 26, 2021Client News

Gunderson Dettmer advised client Natera, Inc., a pioneer and global leader in cell-free DNA testing, in its underwritten public offering of 4,500,000 shares of common stock at a price to the public of $113.00 per share. Morgan Stanley, Goldman Sachs & Co. LLC, Cowen and SVB Leerink acted as joint book-running managers for the offering. Baird, BTIG and Craig-Hallum acted as co-managers for the offering.

Natera’s mission is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera trades on the Nasdaq under the ticker symbol “NTRA.”

The Gunderson deal team was led by capital markets partners Jeff Thacker and Ryan Gunderson, corporate partner John Dietz and associates Leanne Gould and Bettina Tiangco.